MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 200 filers reported holding MEDICINES CO in Q1 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $982,000 | +17.3% | 19,635 | -14.4% | 0.20% | +12.5% |
Q2 2019 | $837,000 | +37.4% | 22,945 | -27.9% | 0.18% | +69.2% |
Q4 2018 | $609,000 | -4.5% | 31,840 | +49.2% | 0.10% | +57.6% |
Q3 2018 | $638,000 | -12.6% | 21,335 | +7.2% | 0.07% | -89.8% |
Q2 2018 | $730,000 | -33.4% | 19,897 | -40.2% | 0.64% | -32.2% |
Q1 2018 | $1,096,000 | +13.8% | 33,271 | -5.5% | 0.95% | -21.3% |
Q4 2017 | $963,000 | -3.9% | 35,217 | +30.1% | 1.21% | +794.8% |
Q3 2017 | $1,002,000 | -2.6% | 27,060 | 0.0% | 0.14% | -12.3% |
Q2 2017 | $1,029,000 | -25.5% | 27,060 | -4.2% | 0.15% | -37.4% |
Q1 2017 | $1,381,000 | +59.3% | 28,251 | +10.6% | 0.25% | -5.0% |
Q4 2016 | $867,000 | +34.6% | 25,534 | +49.6% | 0.26% | -16.7% |
Q3 2016 | $644,000 | +28.3% | 17,070 | +14.4% | 0.31% | -16.6% |
Q2 2016 | $502,000 | +3.1% | 14,919 | -2.7% | 0.37% | -44.4% |
Q1 2016 | $487,000 | -14.9% | 15,331 | 0.0% | 0.67% | -57.3% |
Q4 2015 | $572,000 | – | 15,331 | – | 1.57% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,778,742 | $105,616,000 | 23.17% |
Sarissa Capital Management LP | 3,636,000 | $101,626,000 | 15.30% |
BRIDGER MANAGEMENT, LLC | 2,841,761 | $79,427,000 | 6.29% |
HighVista Strategies LLC | 234,340 | $6,550,000 | 5.34% |
Slate Path Capital LP | 2,170,000 | $60,652,000 | 4.91% |
Camber Capital Management LP | 2,471,523 | $69,079,000 | 3.44% |
Antipodean Advisors LLC | 170,000 | $4,752,000 | 3.38% |
Parian Global Management LP | 152,400 | $4,260,000 | 2.96% |
DLD Asset Management, LP | 2,334,800 | $65,258,000 | 2.40% |
Boxer Capital, LLC | 600,000 | $16,770,000 | 1.94% |